Document is current
Any future updates will be listed below
-
Authors
Wen, Jinkun
Wu, Jinni
Cao, Tianqi
Zhi, Shengyao
Chen, Yuxi
Aagaard, Lars
Zhen, Peilin
Huang, Yanming
Zhong, Jianxin
Huang, Junjiu https://orcid.org/0000-0002-3417-1196
-
Funding
Funding for this research was provided by:
National Key R&D Program of CHina (2017YFC1001901)
National Natural Science Foundation of China (31971365, 31671540)
Guangzhou Science and Technology Project (201803010020)
Guangdong Special Support Program (2019BT02Y276)
Guangdong Basic and Applied Basic Research Foundation (2019A1515010600)
Project funded by China Postdoctoral Science Foundation (2019M653205)
Fundamental Research Funds for the Central Universities (19lgpy195)
- License Information
-
More Information
Article History
Received: 19 June 2020
Accepted: 24 November 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: All procedures involving animals, including generation of transgenic mice, 5-azacytidine treatments, blood sampling and tissue collection, were carried out with the approval of the Institutional Animal Care and Use Committee of Sun Yat-sen University, P.R. China in accordance with the guidelines for the ethical treatments of animals. All efforts were made to minimize the number of animals used and their suffering.
